Skip to content
naulon

Not checkedNot checked for notices yet.

Expression of CD56 isoforms in primary and relapsed adult granulosa cell tumors of the ovary

Kämmerer Ulrike, Schmidt Melanie, Cramer Andreas and 4 more

Diagnostic Pathology · 2008

doi:10.1186/1746-1596-3-29 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Adult granulosa cell tumors of the ovary (GCTs) are sex cord stromal tumors of unpredictable behaviour. Up to now, the prediction of the relapsing/malignant potential remains difficult. CD56 (NCAM) in GCTs was previously described in only two studies. However, the expression of its isoforms was not examined.</p> <p>Methods</p> <p>30 GCTs (16 primaries, 14 relapses) were investigated immunohistochemically with antibodies against Pan-CD56 (CD56<sup>Pan</sup>) and the isoform with 140/180 kDa length (CD56<sup>140/180 kDa</sup>). The reaction was assessed with respect to percentage of positive cells and intensity of staining.</p> <p>Results</p> <p>In all GCTs, CD56<sup>Pan </sup>was expressed, but differences were found between primaries and relapses. The percentage of CD56<sup>Pan </sup>positive tumor cells was lower in relapses, whereas CD56<sup>140/180 kDa </sup>showed a higher staining intensity in the latter.</p> <p>Conclusion</p> <p>Expression of CD56 is an additional sensitive and helpful immunohistochemical tool for histopathologists diagnosing a GCT. It does not seem possible to provide a validly individual risk assessement. However, the different expression of CD56 isoforms might indicate important changes in the course to a more malignant behaviour.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.